+ Add Deal
Company Name Industry Type Initial Engagement Date Initial Investment Follow-on Investment Total Investment Proceeds Upon Exit Cash Out Date Deal Status
Kalocyte Hematology 8/8/2022 500000.00 2.00 500002.00 0.00 Completed
Hemanext Hematology 12/9/2022 1000000.00 0.00 1000000.00 0.00 Completed
Excellos BioTherapy 1/1/0001 1000000.00 0.00 1000000.00 0.00 Completed
CellPhire Hematology 1/1/2024 500000.00 0.00 500000.00 0.00 Completed